TrialThe journal of headache and pain2024

Assessment of prolonged safety and tolerability of erenumab in migraine patients in a long-term open-label study (APOLLON).

Hartmut Göbel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.